🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Thresholds In food allergy evaluaTion And predictioN, a prospective, observ...
Status
Recruiting
Location
McMaster University Medical Centre
Start Date
2023-11-01
Trial ID
NCT06038019
Treatments Being Tested
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
Clinical efficacy and tolerability for allergen specific immunotherapy (AIT...
Status
Completed
Location
Karolinska University Hospital
Start Date
2023-02-01
Trial ID
NCT06085963
Treatments Being Tested
The purpose of the study is to identify prognostic markers and possible suc...
Status
Unknown
Location
Oslo University Hospital, Department of Paediatrics
Start Date
2014-03
Trial ID
NCT02457416
Treatments Being Tested
This phase II trials studies how well pembrolizumab and vactosertib work af...
Status
Terminated
Location
University of California, San Francisco
Start Date
2019-07-22
Trial ID
NCT03844750
Treatments Being Tested
Multicenter, double-blind, randomized, placebo-controlled phase I/II study ...
Status
Recruiting
Location
Clinica Universidad de Navarra
Start Date
2020-03-11
Trial ID
NCT04163562
This study is a multicenter, open-label, randomized controlled trial that e...
Status
Not Yet Recruiting
Location
Peking University Cancer Hospital
Start Date
2025-09-25
Trial ID
NCT07165418
Treatments Being Tested
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
To compare the impact on recurrence risk of adjuvant Sintilimab (a recombin...
Status
Not Yet Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2023-11-01
Trial ID
NCT06089382
Treatments Being Tested
To evaluate the efficacy and safety of Hetrombopag in secondary prevention ...
Status
Not Yet Recruiting
Location
Jiangsu Cancer Hospital
Start Date
2025-08-01
Trial ID
NCT07101627
Treatments Being Tested